This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (231)  • Contact me when this article is cited  Related Content  • Related letter  • Related articles  • Similar articles in JAMA  Topic Collections  • Aging/ Geriatrics  • Neurology  • Alzheimer Disease  • Dementias  • Alert me on articles by topic  Social Bookmarking   What's this?

Kenneth L. Davis, MD; Richard C. Mohs, PhD; Deborah Marin, MD; Dushyant P. Purohit, MD; Daniel P. Perl, MD; Melinda Lantz, MD; Gregory Austin; Vahram Haroutunian, PhD

JAMA. 1999;281:1401-1406.

Context  A central tenet of Alzheimer disease (AD) is the loss of cortical cholinergic function and cholinergic markers in postmortem brain specimens. Whether these profound deficits in cholinergic markers found in end-stage patients are also found in patients with much earlier disease is not known.

Objective  To determine whether cholinergic deficits in AD precede, follow, or occur in synchrony with the earliest signs of cognitive deterioration.

Design, Setting, and Patients  Postmortem study of nursing home residents with Clinical Dementia Rating (CDR) Scale scores of 0.0 to 2.0 and 4.0 to 5.0 who underwent autopsy between 1986 and 1997, comparing the activity of the cholinergic marker enzymes in the cortices of 66 elderly subjects with no (CDR score=0.0; n=18), questionable (CDR score=0.5; n=11), mild (CDR score=1.0; n=22), or moderate (CDR score=2.0; n=15) dementia vs subjects with severe dementia (CDR score=4.0-5.0; n=15).

Main Outcome Measures  Activity of the cholinergic marker enzymes choline acetyltransferase and acetylcholinesterase in 9 neocortical brain regions.

Results  The activity of choline acetyltransferase and acetylcholinesterase in 9 neocortical brain regions did not differ significantly in subjects with CDR scores of 0.0 to 2.0, but was significantly lower in subjects with severe dementia (CDR score=4.0-5.0). Choline acetyltransferase levels were significantly correlated with severity of neuropathological lesions of AD, as measured by density of neuritic plaques and neurofibrillary tangles.

Conclusions  Although neocortical cholinergic deficits are characteristic of severely demented AD patients, in this study, cholinergic deficits were not apparent in individuals with mild AD and were not present until relatively late in the course of the disease. These results suggest that patients with more severe disease should be a target for cholinergic treatment.

Author Affiliations: Departments of Psychiatry (Drs Davis, Mohs, Marin, and Haroutunian and Mr Austin) and Pathology (Drs Purohit and Perl), Mount Sinai School of Medicine, and the Jewish Home and Hospital (Dr Lantz), New York, NY.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Cholinergic Markers in Alzheimer Disease
Raymond T. Bartus, Dwaine F. Emerich, Kenneth L. Davis, Deborah Marin, Dushyant P. Purohit, Daniel Perl, Melinda Lantz, Gregory Austin, and Vahram Haroutunian
JAMA. 1999;282(23):2208-2209.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Challenging the Cholinergic Hypothesis in Alzheimer Disease
Peter Davies
JAMA. 1999;281(15):1433-1434.
EXTRACT | FULL TEXT  

April 21, 1999
JAMA. 1999;281(15):1457-1458.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predisposing Factors Associated With Delirium Among Demented Long-Term Care Residents
Voyer et al.
Clin Nurs Res 2009;18:153-171.
ABSTRACT  

PGC-1{alpha} Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia
Qin et al.
Arch Neurol 2009;66:352-361.
ABSTRACT | FULL TEXT  

Changes in readthrough acetylcholinesterase expression modulate amyloid-beta pathology
Berson et al.
Brain 2008;131:109-119.
ABSTRACT | FULL TEXT  

Superior Frontal Cortex Cholinergic Axon Density in Mild Cognitive Impairment and Early Alzheimer Disease
Ikonomovic et al.
Arch Neurol 2007;64:1312-1317.
ABSTRACT | FULL TEXT  

Statins prevent cholinesterase inhibitor blockade of sympathetic {alpha}7-nAChR-mediated currents in rat superior cervical ganglion neurons
Mozayan and Lee
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H1737-H1744.
ABSTRACT | FULL TEXT  

Donepezil preserves cognition and global function in patients with severe Alzheimer disease
Black et al.
Neurology 2007;69:459-469.
ABSTRACT | FULL TEXT  

A plateau in pre-Alzheimer memory decline: Evidence for compensatory mechanisms?
Smith et al.
Neurology 2007;69:133-139.
ABSTRACT | FULL TEXT  

Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease
Whitwell et al.
Brain 2007;130:708-719.
ABSTRACT | FULL TEXT  

Pathologic and Nicotinic Receptor Binding Differences Between Mild Cognitive Impairment, Alzheimer Disease, and Normal Aging
Sabbagh et al.
Arch Neurol 2006;63:1771-1776.
ABSTRACT | FULL TEXT  

Maintaining adherence and retention in dementia prevention trials.
DeKosky
Neurology 2006;67:S14-S16.
ABSTRACT | FULL TEXT  

Therapeutic approaches to Alzheimer's disease
Klafki et al.
Brain 2006;129:2840-2855.
ABSTRACT | FULL TEXT  

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Prohovnik et al.
Neurology 2006;66:49-55.
ABSTRACT | FULL TEXT  

Pharmacological Modulation of Prefrontal Cortical Activity During a Working Memory Task in Young and Older Humans: A PET Study With Physostigmine
Freo et al.
Am. J. Psychiatry 2005;162:2061-2070.
ABSTRACT | FULL TEXT  

The search for disease modification in moderate to severe Alzheimer disease: A critical review of current evidence
Farlow
Neurology 2005;65:S25-S30.
FULL TEXT  

Cognitive aging and Alzheimer's disease
Vandenberghe and Tournoy
Postgrad. Med. J. 2005;81:343-352.
ABSTRACT | FULL TEXT  

Reduction of Choline Acetyltransferase Activity in Primary Visual Cortex in Mild to Moderate Alzheimer's Disease
Ikonomovic et al.
Arch Neurol 2005;62:425-430.
ABSTRACT | FULL TEXT  

The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi et al.
Neurology 2004;62:1984-1989.
ABSTRACT | FULL TEXT  

Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease
Rockwood
J. Neurol. Neurosurg. Psychiatry 2004;75:677-685.
ABSTRACT | FULL TEXT  

Alzheimer disease without neocortical neurofibrillary tangles: "A second look"
Tiraboschi et al.
Neurology 2004;62:1141-1147.
ABSTRACT | FULL TEXT  

DLB fluctuations: Specific features that reliably differentiate DLB from AD and normal aging
Ferman et al.
Neurology 2004;62:181-187.
ABSTRACT | FULL TEXT  

Septohippocampal Acetylcholine: Involved in but not Necessary for Learning and Memory?
Parent and Baxter
Learn. Mem. 2004;11:9-20.
ABSTRACT | FULL TEXT  

The Cholinergic Lesion of Alzheimer's Disease: Pivotal Factor or Side Show?
Mesulam
Learn. Mem. 2004;11:43-49.
ABSTRACT | FULL TEXT  

Cortical Cholinergic Function Is More Severely Affected in Parkinsonian Dementia Than in Alzheimer Disease: An In Vivo Positron Emission Tomographic Study
Bohnen et al.
Arch Neurol 2003;60:1745-1748.
ABSTRACT | FULL TEXT  

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders
DeKosky and Marek
Science 2003;302:830-834.
ABSTRACT | FULL TEXT  

The Cholinergic Hypothesis of Age and Alzheimer's Disease-Related Cognitive Deficits: Recent Challenges and Their Implications for Novel Drug Development
Terry and Buccafusco
J. Pharmacol. Exp. Ther. 2003;306:821-827.
ABSTRACT | FULL TEXT  

A{beta}1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
Masliah et al.
Neurology 2003;61:206-211.
ABSTRACT | FULL TEXT  

Analysis of Outcome in Retrieved Dropout Patients in a Rivastigmine vs Placebo, 26-Week, Alzheimer Disease Trial
Farlow et al.
Arch Neurol 2003;60:843-848.
ABSTRACT | FULL TEXT  

Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease
Rinne et al.
J. Neurol. Neurosurg. Psychiatry 2003;74:113-115.
ABSTRACT | FULL TEXT  

Early and Widespread Cholinergic Losses Differentiate Dementia With Lewy Bodies From Alzheimer Disease
Tiraboschi et al.
Arch Gen Psychiatry 2002;59:946-951.
ABSTRACT | FULL TEXT  

Relationship between asthma severity and progression of Alzheimer's disease
Ohrui et al.
Thorax 2002;57:561-561.
FULL TEXT  

Stable {beta}-Secretase Activity and Presynaptic Cholinergic Markers During Progressive Central Nervous System Amyloidogenesis in Tg2576 Mice
Gau et al.
Am. J. Pathol. 2002;160:731-738.
ABSTRACT | FULL TEXT  

Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline
Parvathy et al.
Arch Neurol 2001;58:2025-2031.
ABSTRACT | FULL TEXT  

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease
Feldman et al.
Neurology 2001;57:613-620.
ABSTRACT | FULL TEXT  

Attention and Fluctuating Attention in Patients With Dementia With Lewy Bodies and Alzheimer Disease
Ballard et al.
Arch Neurol 2001;58:977-982.
ABSTRACT | FULL TEXT  

Use of Medications With Anticholinergic Effect Predicts Clinical Severity of Delirium Symptoms in Older Medical Inpatients
Han et al.
Arch Intern Med 2001;161:1099-1105.
ABSTRACT | FULL TEXT  

Cholinergic deficits contribute to behavioral disturbance in patients with dementia
Minger et al.
Neurology 2000;55:1460-1467.
ABSTRACT | FULL TEXT  

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
Tiraboschi et al.
Neurology 2000;55:1278-1283.
ABSTRACT | FULL TEXT  

Contribution of Lewy Body Inclusions to Dementia in Patients With and Without Alzheimer Disease Neuropathological Conditions
Haroutunian et al.
Arch Neurol 2000;57:1145-1150.
ABSTRACT | FULL TEXT  

Correlation Between Elevated Levels of Amyloid {beta}-Peptide in the Brain and Cognitive Decline
Naslund et al.
JAMA 2000;283:1571-1577.
ABSTRACT | FULL TEXT  

Nerve Growth Factor (NGF) Augments Cortical and Hippocampal Cholinergic Functioning after p75NGF Receptor-Mediated Deafferentation But Impairs Inhibitory Avoidance and Induces Fear-Related Behaviors
Winkler et al.
J. Neurosci. 2000;20:834-844.
ABSTRACT | FULL TEXT  

Cholinergic Markers in Alzheimer Disease
Bartus et al.
JAMA 1999;282:2208-2209.
FULL TEXT  

Neuropeptide Abnormalities in Patients With Early Alzheimer Disease
Davis et al.
Arch Gen Psychiatry 1999;56:981-987.
ABSTRACT | FULL TEXT  

Neuropharmacology and Receptor Studies in the Elderly
Meltzer
J Geriatr Psychiatry Neurol 1999;12:137-149.
ABSTRACT  

Cholinergic Markers in AD
JWatch Psychiatry 1999;1999:8-8.
FULL TEXT  

Challenging the Cholinergic Hypothesis in Alzheimer Disease
Davies
JAMA 1999;281:1433-1434.
FULL TEXT